A branched fluorescent peptide probe for imaging of activated platelets.

TitleA branched fluorescent peptide probe for imaging of activated platelets.
Publication TypeJournal Article
Year of Publication2005
AuthorsTung C-H, Quinti L, Jaffer FA, Weissleder R
JournalMol Pharm
Volume2
Issue1
Pagination92-5
Date Published2005 Jan-Feb
ISSN1543-8384
KeywordsBlood Platelets, Diagnostic Imaging, Fibrinogen, Fluorescence, Fluorescent Dyes, Humans, Models, Biological, Peptides, Platelet Activation, Platelet Glycoprotein GPIIb-IIIa Complex, Thrombosis
Abstract

Novel fluorescent probes for thrombi and activated-platelet detection were developed that were based on the glycoprotein IIb/IIIa (GP-IIb/IIIa) binding sequence, Pro-Ser-Pro-Gly-Asp-Trp. Linear, Pro-Ser-Pro-Gly-Asp-Trp-Aha-Gly-Cys(Cy5.5)-NH(2) (1PF), and branched, (Pro-Ser-Pro-Gly-Asp-Trp-Aha)(2)-Lys-Gly-Cys(Cy5.5)-NH(2) (2PF), fluorescent-labeled peptide probes were synthesized. A third probe, also branched, (Pro-Ser-Pro-Gly-Glu-Trp-Aha)(2)-Lys-Gly-Cys(Cy5.5)-NH(2) (2CF), was synthesized as control. The platelet-binding activity of the probes was tested in clots generated from human platelet-rich plasma. Fluorescence reflectance imaging results showed that 2PF has a 16-fold increase in fluorescence intensity compared to the autofluorescence of clots. The linear conjugate, 1PF, and free dye did not show appreciable fluorescence enhancement. 2PF fluorescence was also found 5.5-fold higher than that of the control probe, 2CF. Overall, our results suggest that 2PF binds tightly to GP-IIb/IIIa and potentially can be used for in vivo imaging of thrombosis.

DOI10.1021/mp0499048
Alternate JournalMol Pharm
PubMed ID15804182
Grant ListP50 CA 86355 / CA / NCI NIH HHS / United States
R01 CA 99385 / CA / NCI NIH HHS / United States
Related Institute: 
Molecular Imaging Innovations Institute (MI3)

Weill Cornell Medicine
Department of Radiology
525 East 68th Street New York, NY 10065